±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 320  |  »Ø¸´: 2

madai26

¶Ò»»¹ó±ö

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡

[½»Á÷] ¡¾ÇóÖú¡¿ÓÐûÓгæ×Ó°ïÎÒ²éÒ»ÏÂfasidotrilÕâ¸öÒ©ÔÚ¹úÍâÓÐûÓÐÉÏÊУ¿ ÒÑÓÐ2È˲ÎÓë

ÒòΪÎÒÃǵ¥Î»Ã»É¶Êý¾Ý¿â£¬ËùÒԲ鲻µ½¡£

fasidotril ·¨Î÷¶àÇú
ACE/NEPË«ÏòÒÖÖÆ¼Á

ÁÙ´²ÊÔÑé×öµ½3ÆÚ£¬µ«ºóÀ´¾ÍûÏÂÎÄÁË£¬ÄÄλºÃÐĵijæ×Ó°ï¸öÃ¦ÄØ£¿°ïÎÒ°ÑËüÓÐûÓÐÉÏÊУ¬ÔÚÄÄÉÏÊеIJéһϣ¿
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

nkbeholder

¹ÜÀíÔ±

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡

¡ï ¡ï
madai26(½ð±Ò+2):лл²ÎÓë
warlen(½ð±Ò+1):лл²ÎÓë 2010-08-04 15:15:09
ÕâÉÏÃæÐ´µ½2ÆÚ¾ÍÖÐÖ¹ÁË¡£


Originator Company: Bioprojet (France)
Parent Company: Bioprojet
Licensee: Eli Lilly

Highest Phase: Discontinued II

Development Status:

Discontinued II, France, Congestive heart failure
Discontinued II, France, Hypertension
Discontinued Preclinical, France, Postmyocardial infarction
Introduction:
Fasidotril, the prodrug of its active metabolite fasidoprilat, is a mixed inhibitor of ACE and neutral endopeptidase. It was undergoing phase II development with Bioprojet in France for the treatment of congestive heart failure and hypertension. It was also in preclinical development for postmyocardial infarction. However, development appears to have been discontinued.

In October 2001, Bioprojet and Eli Lilly announced a development and commercialisation collaboration. Under the terms of the agreement, Lilly received exclusive worldwide commercialisation rights excluding Japan and certain countries in Europe. Lilly was to continue to develop fasidotril through to registration, and was to manufacture the finished product; Bioprojet was to manufacture the bulk material.
2Â¥2010-08-04 14:45:13
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

mrzouhao

°æÖ÷

ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡ÓÅÐ㣡£¡ÓÐľÓУ¡£¡£¡

¡ï
madai26(½ð±Ò+1):лл²ÎÓë
fasidotril ·¨Î÷¶àÇú
ÒÑÖÕÖ¹ÁÙ´²Ñо¿£¬lilly·ÅÆúÁË
3Â¥2010-08-04 15:13:10
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ madai26 µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 270Çóµ÷¼Á +5 С½Üpp 2026-03-31 6/300 2026-04-01 20:49 by cqupH
[¿¼ÑÐ] Çóµ÷¼ÁÍÆ¼ö ²ÄÁÏ 304 +20 ºÉ°üµ°hyj 2026-03-26 20/1000 2026-04-01 20:46 by Àµ´ºÑÞ
[¿¼ÑÐ] 292Çóµ÷¼Á +15 ľ³æer12138 2026-04-01 15/750 2026-04-01 20:42 by cqupH
[¿¼ÑÐ] 282Çóµ÷¼Á +16 ycy1201 2026-04-01 18/900 2026-04-01 20:36 by Àµ´ºÑÞ
[¿¼ÑÐ] 291Çóµ÷¼Á +17 Y-cap 2026-03-29 21/1050 2026-04-01 20:13 by Àµ´ºÑÞ
[¿¼ÑÐ] Ó¢Ò»Êý¶þÉúÎïÐÅϢѧ287·Ö£¬±¾¿ÆÉúÎï¿ÆÑ§£¬Çóµ÷¼Á +3 ±ÌË®xyz 2026-03-29 4/200 2026-04-01 15:35 by plum
[¿¼ÑÐ] 279Çóµ÷¼Á +6 Īxiao 2026-04-01 6/300 2026-04-01 11:11 by ÄæË®³Ë·ç
[¿¼ÑÐ] 358Çóµ÷¼Á +3 ÍõÏòÑô»¨ 2026-03-31 3/150 2026-04-01 09:56 by zzchen2000
[¿¼ÑÐ] ¿¼ÑÐÉúÎïÓëÒ½Ò©µ÷¼Á +7 Ìúº©º©123425 2026-03-31 7/350 2026-04-01 08:45 by JourneyLucky
[¿¼ÑÐ] ±¾2Ò»Ö¾Ô¸C9-333·Ö£¬²ÄÁÏ¿ÆÑ§Ó빤³Ì£¬Çóµ÷¼Á +9 ÉýÉý²»½µ 2026-03-31 9/450 2026-03-31 18:01 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 0856 335·Ö | ·â×°or¼¤¹â¼Ó¹¤ ÀÏʦ¿´¿´ÎÒ£¡£¡ +9 cccchenso 2026-03-29 9/450 2026-03-31 16:37 by lishahe
[»ù½ðÉêÇë] ÃæÉÏ5BÄÜÉÏ»áÂ𣿠+8 redcom 2026-03-29 8/400 2026-03-31 15:53 by niuailing
[¿¼ÑÐ] 272Çóµ÷¼Á£¬½ÓÊÜ¿çרҵµ÷¼Á£¡ +3 ÏÐÓ㬠2026-03-31 3/150 2026-03-31 13:00 by Ìæ´úÆ·000
[¿¼ÑÐ] 105500ҩѧÇóµ÷¼Á£¬Ò»Ö¾Ô¸É½¶«´óѧҩѧ£¬348·Ö +3 gr¹þ¹þ¹þ 2026-03-28 3/150 2026-03-30 18:56 by Ô´_2020
[¿¼ÑÐ] 298Çóµ÷¼Á +3 ʲôÊÇÅÖÍ·Óã 2026-03-30 5/250 2026-03-30 14:41 by ÇຣСÎ÷Å£
[¿¼ÑÐ] 085600£¬×¨Òµ¿Î»¯¹¤Ô­Àí£¬321·ÖÇóµ÷¼Á +5 ´ó²öС×Ó 2026-03-28 5/250 2026-03-29 08:56 by qingfeng258
[¿¼ÑÐ] 292Çóµ÷¼Á +4 ÇóÇóÁËÊÕÏÂÎÒ°É£ 2026-03-26 4/200 2026-03-27 10:37 by zhshch
[¿¼ÑÐ] µ÷¼ÁÇóÊÕÁô +7 ¹ûÈ»ÓÐÎÒ 2026-03-26 7/350 2026-03-27 00:26 by wxiongid
[¿¼ÑÐ] µ÷¼Á +4 èÖèÖyoyo 2026-03-26 4/200 2026-03-26 20:43 by fmesaito
[¿¼ÑÐ] 081200-11408-276ѧ˶Çóµ÷¼Á +3 ´Þwj 2026-03-26 3/150 2026-03-26 19:57 by nihaoar
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û